ARCHIVES

Phase II Trial of BIND-014 Shows Anti-Tumor Activity in Q3W Arm

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

ASCO Defines Clinically Meaningful Outcomes

April 25, 2013

National Lung Cancer Partnership Announces Annual Grant Competition

August 9, 2013

BMI May Be Prognostic Tool For Types Of Breast Cancer

March 28, 2008

Continuing Resolution Expires March 27; NIH, NCI Hope For Budget Compromise

March 15, 2013

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

July 25, 1975

DCT Board Questions Funding, Direction Of IL-2/LAK Trials

March 3, 1989